Učitavanje...
Toll-Like Receptor 9 Agonists for Cancer Therapy
The immune system has acquired increasing importance as a key player in cancer maintenance and growth. Thus, modulating anti-tumor immune mediators has become an attractive strategy for cancer treatment. Toll-like receptors (TLRs) have gradually emerged as potential targets of newer immunotherapies....
Spremljeno u:
| Izdano u: | Biomedicines |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5344222/ https://ncbi.nlm.nih.gov/pubmed/28548068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines2030211 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|